Category: Medicine

Head of the Pears Cumbria School of Medicine

Professor Mary Morrell has been appointed as Head of the Pears Cumbria School of Medicine, with effect from 1 November 2024.

Professor Morrell has been the Interim Head of the Pears Cumbria School of Medicine since the School was formed in August 2023.

Professor Morrell joined Imperial as a lecturer in 2000. Since then she has held many senior educational roles, including the Director of Phase 1 and its ‘early years’ predecessor within Imperial College School of Medicine (ICSM). Professor Morrell has also facilitated and supported programmes in NHLI, including the successful BSc pathway in Remote Medicine, the first of its kind in the UK, and the Cardiovascular and Respiratory Healthcare MSc.

Professor Morrell’s research has investigated and raised awareness of sleep-related health issues in the UK and her research continues to have impact on the clinical care of thousands of patients.

Professor Morrell would love to hear from anyone interested in the new School. Please do get in contact.

Director of the Academic Health Science Centre (AHSC)

Professor Mark Thursz has accepted the appointment of Director of the Academic Health Science Centre (AHSC), with effect from 1 August 2024, for a term of five years. He succeeds Professor Jonathan Weber who had held this position since 2012. We express our thanks to Professor Weber for his long stint in office and for his unwavering commitment to the AHSC and its NHS partners and to Imperial College London.

Professor Thursz has been the Head of the Department of Metabolism, Digestion and Reproduction (MDR) since 2019, a role he will step down from in due course once a new postholder is identified and takes up the post.

Professor Thursz joined Imperial in 1991 as a clinical research fellow and was appointed to a Senior Lectureship in 1997. He was promoted to Professor of Hepatology in 2006. He has held many senior roles within the Department and Faculty, including Head of the Division of Digestive Diseases within MDR, and St Mary’s Campus Director.

He is R&D Director at Imperial College Healthcare NHS Trust, where he is a consultant hepatologist based at St Mary’s Hospital. He is also Director of the NIHR Imperial Biomedical Research Centre, which in 2022 was awarded a five-year grant of over £95M from the NIHR to support research activity in collaboration with Imperial College London.

Professor Thursz is a former secretary of the British Association for Study of the Liver (BASL) and led the European Association for Study of the Liver, as Secretary-General (2011-13). Professor Thursz’s research interests are focussed on viral hepatitis and alcohol-related liver disease. He established the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFCA) programme to address barriers that prevent the control and elimination of viral hepatitis in countries with limited resources. He also runs a translational research programme in alcohol-related liver disease funded by the MRC and NIHR.

Deputy Dean of the Faculty of Medicine

Professor Graham Cooke has accepted appointment as Deputy Dean of the Faculty of Medicine, with effect from 1 August 2024, for a term of five years. 

Professor Cooke will continue in his role as Vice-Dean (Research) for the Faculty of Medicine. Professor Cooke is also currently serving as Deputy Head of the Department of Infectious Disease, a role which he will step down once he takes on the role of Deputy Dean of the Faculty. 

(more…)

Head of the National Heart and Lung Institute

Professor Barbara Casadei, MD DPhil FRCP FMedSci, has accepted the appointment of Head of the National Heart and Lung Institute (NHLI) for a term of five years, and Professor of Cardiovascular Medicine, with effect from 1 October 2024.

Professor Casadei holds the British Heart Foundation (BHF) Professor of Cardiovascular Medicine at the University of Oxford and is an Honorary Consultant in Cardiovascular Medicine at the Oxford University Hospitals NHS Trust.

Professor Casadei is a Steering Committee Member of the Oxford BHF Centre for Research Excellence and Lead of the Cardiovascular Theme of the NIHR Oxford Biomedical Research Centre. She has been in the Board of Trustees of the Association of Physicians of Great Britain & Ireland, since 2021.

Professor Casadei has served on several other senior roles within the University of Oxford such as Lead of the Myocardial Biology Theme of the Oxford BHF Centre of Research Excellence and Deputy Head of the Division of Cardiovascular Medicine.

She was Elected President of the European Society of Cardiology in 2018 and served until 2020. She served as Board member of the World Heart Federation (2020-22).

Professor Casadei was elected Fellow of the UK Academy of Medical Sciences (FMedsci), in 2013. She was awarded the Honorary International Fellowship of the American Heart Association (FAHA), in 2018 and was awarded both The Gold Medal of the European Society of Cardiology, and The Mackenzie Medal of the British Cardiovascular Society, in 2020.  

Professor Casadei will take over from Professor Clare Lloyd who, as Interim Head of the NHLI, has been responsible for introducing many improvements and innovations, providing strategic vision, direction, and leadership to the Institute.

Extension of Terms of Offices within Faculty of Medicine

Professor Marina Botto FMedSci has accepted an extension to her term of office as Head of the Department of Immunology and Inflammation, in the Faculty of Medicine, by a further three years, until 31 July 2027.

Professor Botto is also the Interim Head of the Department of Brain Sciences and will continue so until we recruit the permanent Head. Professor Botto holds a Chair in Rheumatology in the Department of Immunology and Inflammation and also serves as Director of Bioservices at Imperial. Professor Botto’s clinical work is based at Hammersmith Hospital.

Professor Botto’s research focuses on how complement deficiency contributes to the autoimmune disease systemic lupus erythematosus (SLE).

Professor Mark Thursz has accepted an extension to his term of office as Head of the Department of Metabolism, Digestion and Reproduction, in the Faculty of Medicine, by a further three years, until 31 July 2027.

Mark Thursz is Professor of Hepatology in the Department. His clinical work is based at the St Mary’s Hospital. He has held many senior roles within the Department and Faculty, including currently Director Imperial Biomedical Research Centre, the Imperial College Healthcare NHS Trust Research Director, Head of Division of Digestive Diseases within the Department, and previously was St Mary’s Campus Director.

Professor Thursz’ research interests are focussed on alcohol-related liver disease, MAFLD and viral hepatitis.

Professor Wendy Barclay CBE  FMedSci has accepted an extension to her term of office as Head of the Department of Infectious Disease, in the Faculty of Medicine, by a further year, until 31 July 2025.

Professor Barclay holds the Action Medical Research Chair in Virology within the Department.

Professor Barclay’s expertise is in the field of respiratory viruses, in particular influenza viruses. Her studies aim to understand the molecular and cellular basis of the pathogenesis, host range restrictions and transmissibility of influenza viruses.

Professor Barclay was awarded a CBE for her contributions to the study of viruses and her research during the COVID-19 pandemic.

Professor Clare Lloyd FMedSci has accepted an extension to her term of office as Vice-Dean (Institutional Affairs) for the Faculty of Medicine, by a further two years, until 31 May 2026.

Professor Lloyd holds the Chair in Respiratory Immunology in the National Heart and Lung Institute (NHLI) and was the NHLI’s first Institute Lead for Women from 2008-2014. Professor Lloyd has been the Interim Head of the NHLI since June 2023 and will continue in this interim role until the new Head of NHLI takes up the post.

Her research focuses on the development and regulation of immune responses in the lung, particularly the inception of allergic immunity in early life.

Interim Head of the Department of Brain Sciences

Professor Marina Botto FMedSci has accepted an appointment as Interim Head of the Department of Brain Sciences with effect from 8 April 2024 for a period of six months, in the first instance. This is to succeed the current Head of the Department, Professor Paul Matthews, who is taking up the post of Director of the Rosalind Franklin Institute, in Cambridge.

(more…)

Head of the Department of Surgery and Cancer

Professor George Hanna FMedSci has accepted an extension to his appointment as Head of the Department of Surgery and Cancer until 31 January 2027.

Professor Hanna is currently Head of the Division of Surgery within the department and holds a chair in Surgical Sciences. Professor Hanna’s clinical work is based at Hammersmith Hospital, Imperial College Healthcare NHS Trust in oesophageal and gastric cancer surgery.

The current interest of his laboratory revolves around volatile organic compounds analysis to investigate molecular drivers of volatile biomarkers and develop a non-invasive breath test as a platform technology to detect gastrointestinal cancers. He leads an NIHR Health Technology Centre in In-Vitor Diagnostics.

Dean of the Faculty of Medicine

Professor Deborah Ashby has accepted the appointment as Dean of the Faculty of Medicine, for a term of five years, effective from 1 January 2024.  Professor Ashby has been the interim Dean since 1 August 2023 following Professor Jonathan Weber’s retirement as Dean. 

Reporting to the Provost, the Dean of the Faculty of Medicine is responsible for all aspects of the Faculty’s strategy, operations and finances. As Dean, Professor Ashby will also be a member of Imperial’s Council and its University Management Board (UMB).  

(more…)

Director of the School of Public Health

Professor Neil Ferguson has accepted appointment as Director of the School of Public Health in the Faculty of Medicine, with effect from 1 August 2023 for a term of five years.    

Reporting to the Interim Dean of the Faculty of Medicine, Professor Ferguson will provide strategic vision, direction and leadership to the School of Public Health and will ensure that appropriate plans, management and governance structures and practices are in place.  

(more…)

Interim Head of the National Heart and Lung Institute (NHLI)

Professor Clare Lloyd FMedSci, has accepted the appointment of Interim Head of the National Heart and Lung Institute (NHLI) with effect from 1 June 2023, for an initial period of six months, or until a new Head is identified and appointed. 

Professor Lloyd joined Imperial in 1999 as a Welcome Senior Research Fellow, and was promoted to Professor of Respiratory Immunology in 2006. She was the NHLI’s first Institute Lead for Women from 2008-2014. Professor Lloyd is currently Vice-Dean (Institutional Affairs) for the Faculty of Medicine. 

(more…)